Related Experiment Video
Updated: Jun 8, 2025

Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
Advanced Endoscopic Imaging to Predict Clinical Outcomes in Inflammatory Bowel Disease
Udayakumar Navaneethan1, Dennisdhilak Lourdusamy2
1Center for Inflammatory Bowel Disease and Interventional Inflammatory Bowel Disease, Orlando Health, Orlando Health Digestive Health Institute, 22 West Underwood Street, Orlando, FL 32806, USA.
Advanced endoscopic imaging, including confocal laser endomicroscopy (CLE) and endocytoscopy (EC), shows promise in predicting inflammatory bowel disease (IBD) outcomes by assessing gut barrier function and histologic activity.
Area of Science:
- Gastroenterology and Hepatology
- Medical Imaging
- Inflammatory Bowel Disease Research
Background:
- Inflammatory Bowel Disease (IBD) management benefits from accurate outcome prediction.
- Current methods for assessing IBD activity and prognosis have limitations.
- Advanced endoscopic imaging offers novel approaches to evaluate IBD.
Purpose of the Study:
- To evaluate the role of advanced endoscopic imaging techniques in predicting clinical outcomes for patients with IBD.
- To explore the utility of confocal laser endomicroscopy (CLE) and endocytoscopy (EC) in IBD management.
Main Methods:
- Review of advanced endoscopic imaging modalities: high-definition endoscopy, CLE, and EC.
- Assessment of CLE's ability to identify gut barrier dysfunction.
- Evaluation of EC's capability for histologic activity assessment.
Main Results:
- Confocal laser endomicroscopy (CLE) identifies gut barrier dysfunction, which correlates with IBD disease behavior and long-term outcomes.
- Endocytoscopy (EC) enables direct assessment of histologic activity in IBD.
- These advanced imaging techniques show potential as adjuncts for predicting IBD clinical outcomes.
Conclusions:
- Advanced endoscopic imaging, including CLE and EC, holds promise for improving the prediction of clinical outcomes in IBD.
- Further controlled studies are necessary to establish the definitive role of these technologies in IBD patient management.
More Related Videos
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...